Hers vs Sprout Health: FDA Brand vs Compounded GLP-1 Choices
Choosing between Hers and Sprout Health comes down to brand-name FDA approval versus a fast, lower-friction compounded option. Early verdict: Hers emphasizes FDA-approved Wegovy® and a structured membership model starting at $149/mo, while Sprout Health emphasizes quick approval and a $50 off first month promotional entry that brings the initial cost to $199.
See Hers’ FDA-approved Wegovy® plans
Hers vs Sprout Health at a glance
This comparison focuses on pricing and promotions, medication regulatory status, onboarding speed and approval, membership and billing requirements, and outcome framing or marketing claims.
| Criteria | Hers | Sprout Health |
|---|---|---|
| Starting price | From $149/mo (Wegovy® pill) | $50 off first month, bringing it to $199 initial |
| Ongoing price | From $199/mo for injectable semaglutide; membership required | $249/month ongoing after discount |
| Medication type | FDA-approved Wegovy® (brand-name semaglutide); no compounded medications | Compounded semaglutide only (not an FDA-approved finished product) |
| Onboarding speed | Personalized care team with ongoing dose check-ins; clinician review required | Lightning-quick approval and fast, hassle-free entry after online intake |
| Outcome framing | Uses doctor-trusted GLP-1s and name-brand medication; no formal outcome guarantee provided | Frames outcomes as 10–26% body weight loss in 12 months in marketing; no published outcome guarantee |
Pricing, discounts, and membership differences
Both providers use direct-pay models. Hers lists Wegovy® pill from $149/mo and injectable semaglutide from $199/mo, and notes that an active Hers Weight Loss Membership is required ($39 for the first month, auto-renews at $149/month thereafter). Sprout Health advertises a promotional $50 off the first month, bringing the first month to $199, with ongoing pricing at $249/month after the discount. The Sprout Health capture also notes the $249 ongoing rate is higher than several competitors. Membership and renewal terms are explicitly called out by Hers; Sprout Health’s captured evidence emphasizes a lower-friction enrollment and an introductory discount.
Check Hers pricing and membership details
Medication regulatory status and formulation
Hers offers FDA-approved Wegovy® (brand-name semaglutide) and states no compounded medications are offered. The source repeatedly emphasizes name-brand FDA-approved options and that compounded medications, when offered by others, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Sprout Health, by contrast, is presented in the captured evidence as prescribing compounded semaglutide after clinician review; the material notes compounded medication is not an FDA-approved finished product and patients should confirm medication-specific approval status.
Onboarding speed and clinical review
Sprout Health positions itself on fast onboarding and lightning-quick approval following online intake, highlighting rapid prescription review and shipment. Hers highlights a personalized care team with ongoing dose check-ins and notes treatment is available only when a licensed clinician determines it is medically appropriate. Both require clinician review and a prescription determined medically appropriate, so speed and personalization are trade-offs: Sprout Health markets rapid entry, Hers emphasizes ongoing clinical oversight.
Start Sprout Health’s fast approval process
Outcome messaging and expectations
Sprout Health frames outcomes as 10–26% body weight loss over 12 months based on GLP-1 literature and markets that range clearly. The capture explicitly says individual results vary and Sprout Health does not offer a formal outcome guarantee. Hers highlights FDA-approved options and examples of weight change timelines in marketing, but does not provide a formal guarantee in the captured evidence. Both note treatment is available only when a licensed clinician determines it is medically appropriate.
How the differences matter
- Regulatory comfort: If having a brand-name FDA-approved product is essential, Hers documents offering Wegovy® and not offering compounded medications.
- Cost entry and ongoing cost: Sprout Health’s captured evidence centers on a $50 off first month promotion to reach $199 initially, with $249 ongoing; Hers lists lower starting options but requires a membership with specific billing terms.
- Speed versus clinical check-ins: Sprout Health advertises lightning-quick approval; Hers emphasizes a personalized care team and ongoing dose check-ins.
See Sprout Health offer and details
Conclusion: Hers vs Sprout Health
Hers vs Sprout Health comes down to a choice between FDA-approved Wegovy® with a membership and structured follow-up (Hers) and a fast-entry, promotional compounded semaglutide option (Sprout Health). Hers emphasizes brand-name, FDA-approved medication and ongoing clinician check-ins, with pricing that starts at $149/mo and a membership requirement. Sprout Health emphasizes lightning-quick approval and a $50 first-month discount to $199 initial, with ongoing $249/month after the discount and compounded medication only.
Choose Hers if you prioritize FDA-approved Wegovy® and ongoing dose check-ins and accept the membership requirement. Choose Sprout Health if you prioritize quick approval and an introductory $50-off first month entry to compounded semaglutide.
Choose Hers if you want brand-name, FDA-approved semaglutide with a structured care team and are willing to enroll in the Hers membership. Choose Sprout Health if you want a fast, low-friction start and an initial $50-off promotional price knowing the product is compounded and ongoing pricing rises to $249/month.